AIMS: Nrf2 is a master transcription factor for antioxidant response element (ARE)-mediated cytoprotective gene induction. A protective role for pulmonary Nrf2 was determined in model oxidative disorders, including hyperoxia-induced acute lung injury (ALI). To obtain additional insights into the function and genetic regulation of Nrf2, we assessed functional single nucleotide polymorphisms (SNPs) of Nrf2 in inbred mouse strains and tested whether sequence variation is associated with hyperoxia susceptibility. RESULTS: Nrf2 SNPs were compiled from publicly available databases and by re-sequencing DNA from inbred strains. Hierarchical clustering of Nrf2 SNPs categorized the strains into three major haplotypes. Hyperoxia susceptibility was greater in haplotypes 2 and 3 strains than in haplotype 1 strains. A promoter SNP -103 T/C adding an Sp1 binding site in haplotype 2 diminished promoter activation basally and under hyperoxia. Haplotype 3 mice bearing nonsynonymous coding SNPs located in (1862 A/T, His543Gln) and adjacent to (1417 T/C, Thr395Ile) the Neh1 domain showed suppressed nuclear transactivation of pulmonary Nrf2 relative to other strains, and overexpression of haplotype 3 Nrf2 showed lower ARE responsiveness than overexpression of haplotype 1 Nrf2 in airway cells. Importantly, we found a significant correlation of Nrf2 haplotypes and hyperoxic lung injury phenotypes. INNOVATION AND CONCLUSION: The results indicate significant influence of Nrf2 polymorphisms and haplotypes on gene function and hyperoxia susceptibility. Our findings further support Nrf2 as a genetic determinant in ALI pathogenesis and provide useful tools for investigators who use mouse strains classified by Nrf2 haplotypes to elucidate the role for Nrf2 in oxidative disorders.
AIMS: Nrf2 is a master transcription factor for antioxidant response element (ARE)-mediated cytoprotective gene induction. A protective role for pulmonary Nrf2 was determined in model oxidative disorders, including hyperoxia-induced acute lung injury (ALI). To obtain additional insights into the function and genetic regulation of Nrf2, we assessed functional single nucleotide polymorphisms (SNPs) of Nrf2 in inbred mouse strains and tested whether sequence variation is associated with hyperoxia susceptibility. RESULTS:Nrf2 SNPs were compiled from publicly available databases and by re-sequencing DNA from inbred strains. Hierarchical clustering of Nrf2 SNPs categorized the strains into three major haplotypes. Hyperoxia susceptibility was greater in haplotypes 2 and 3 strains than in haplotype 1 strains. A promoter SNP -103 T/C adding an Sp1 binding site in haplotype 2 diminished promoter activation basally and under hyperoxia. Haplotype 3 mice bearing nonsynonymous coding SNPs located in (1862 A/T, His543Gln) and adjacent to (1417 T/C, Thr395Ile) the Neh1 domain showed suppressed nuclear transactivation of pulmonary Nrf2 relative to other strains, and overexpression of haplotype 3 Nrf2 showed lower ARE responsiveness than overexpression of haplotype 1 Nrf2 in airway cells. Importantly, we found a significant correlation of Nrf2 haplotypes and hyperoxic lung injury phenotypes. INNOVATION AND CONCLUSION: The results indicate significant influence of Nrf2 polymorphisms and haplotypes on gene function and hyperoxia susceptibility. Our findings further support Nrf2 as a genetic determinant in ALI pathogenesis and provide useful tools for investigators who use mouse strains classified by Nrf2 haplotypes to elucidate the role for Nrf2 in oxidative disorders.
Authors: Hye-Youn Cho; Bennett van Houten; Xuting Wang; Laura Miller-DeGraff; Jennifer Fostel; Wesley Gladwell; Ligon Perrow; Vijayalakshmi Panduri; Lester Kobzik; Masayuki Yamamoto; Douglas A Bell; Steven R Kleeberger Journal: Antioxid Redox Signal Date: 2012-04-18 Impact factor: 8.401
Authors: Hye-Youn Cho; Anne E Jedlicka; Sekhar P M Reddy; Liu-Yi Zhang; Thomas W Kensler; Steven R Kleeberger Journal: Am J Respir Cell Mol Biol Date: 2002-01 Impact factor: 6.914
Authors: Chaim O Jacob; Miriam Eisenstein; Mary C Dinauer; Wenyu Ming; Qiang Liu; Sutha John; Francesco P Quismorio; Andreas Reiff; Barry L Myones; Kenneth M Kaufman; Deborah McCurdy; John B Harley; Earl Silverman; Robert P Kimberly; Timothy J Vyse; Patrick M Gaffney; Kathy L Moser; Marisa Klein-Gitelman; Linda Wagner-Weiner; Carl D Langefeld; Don L Armstrong; Raphael Zidovetzki Journal: Proc Natl Acad Sci U S A Date: 2011-12-27 Impact factor: 11.205
Authors: Jennifer L Nichols; Wesley Gladwell; Kirsten C Verhein; Hye-Youn Cho; Jürgen Wess; Oscar Suzuki; Tim Wiltshire; Steven R Kleeberger Journal: FASEB J Date: 2014-02-26 Impact factor: 5.191
Authors: June K Dunnick; Keith R Shockley; Daniel L Morgan; Amy Brix; Gregory S Travlos; Kevin Gerrish; J Michael Sanders; T V Ton; Arun R Pandiri Journal: Arch Toxicol Date: 2016-09-16 Impact factor: 5.153
Authors: Lu Fan; Ye Fan; Li Liu; Weiwei Tao; Xin Shan; Yu Dong; Lin Li; Sen Zhang; Hanqing Wang Journal: Front Pharmacol Date: 2018-09-26 Impact factor: 5.810
Authors: Montserrat Rojo de la Vega; Matthew Dodson; Christine Gross; Heidi M Mansour; R Clark Lantz; Eli Chapman; Ting Wang; Stephen M Black; Joe G N Garcia; Donna D Zhang Journal: Curr Pharmacol Rep Date: 2016-02-06